EMMPRIN reduction via scFv-M6-1B9 intrabody affects α3β1- integrin and MCT1 functions and results in suppression of progressive phenotype in the colorectal cancer cell line Caco-2

Extracellular matrix metalloproteinase inducer (EMMPRIN) exhibits overexpression in various cancers and promotes cancer progression and metastasis via the interaction with its associated molecules. The scFv-M6-1B9 intrabody has a potential ability to reduce EMMPRIN cell surface expression. However,...

Full description

Saved in:
Bibliographic Details
Main Authors: S. Sangboonruang, P. Thammasit, N. Intasai, W. Kasinrerk, C. Tayapiwatana, K. Tragoolpua
Format: Journal
Published: 2018
Online Access:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84903593918&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/45468
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University
id th-cmuir.6653943832-45468
record_format dspace
spelling th-cmuir.6653943832-454682018-01-24T06:10:52Z EMMPRIN reduction via scFv-M6-1B9 intrabody affects α3β1- integrin and MCT1 functions and results in suppression of progressive phenotype in the colorectal cancer cell line Caco-2 S. Sangboonruang P. Thammasit N. Intasai W. Kasinrerk C. Tayapiwatana K. Tragoolpua Extracellular matrix metalloproteinase inducer (EMMPRIN) exhibits overexpression in various cancers and promotes cancer progression and metastasis via the interaction with its associated molecules. The scFv-M6-1B9 intrabody has a potential ability to reduce EMMPRIN cell surface expression. However, the subsequent effect of scFv-M6-1B9 intrabody-mediated EMMPRIN abatement on its related molecules, α3β1-integrin, MCT1, MMP-2 and MMP-9, is undefined. Our results demonstrated that the scFv-M6-1B9 intrabody efficiently decreased α3β1-integrin cell surface expression levels. In addition, intracellular accumulation of MCT1 and lactate were increased. These results lead to suppression of features characteristic for tumor progression, including cell migration, proliferation and invasion, in a colorectal cancer cell line (Caco-2) although there was no difference in MMP expression. Thus, EMMPRIN represents an attractive target molecule for the disruption of cancer proliferation and metastasis. An scFv-M6-1B9 intrabody-based approach could be relevant for cancer gene therapy. © 2014 Nature America, Inc. All rights reserved. 2018-01-24T06:10:52Z 2018-01-24T06:10:52Z 2014-01-01 Journal 14765500 09291903 2-s2.0-84903593918 10.1038/cgt.2014.24 https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84903593918&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/45468
institution Chiang Mai University
building Chiang Mai University Library
country Thailand
collection CMU Intellectual Repository
description Extracellular matrix metalloproteinase inducer (EMMPRIN) exhibits overexpression in various cancers and promotes cancer progression and metastasis via the interaction with its associated molecules. The scFv-M6-1B9 intrabody has a potential ability to reduce EMMPRIN cell surface expression. However, the subsequent effect of scFv-M6-1B9 intrabody-mediated EMMPRIN abatement on its related molecules, α3β1-integrin, MCT1, MMP-2 and MMP-9, is undefined. Our results demonstrated that the scFv-M6-1B9 intrabody efficiently decreased α3β1-integrin cell surface expression levels. In addition, intracellular accumulation of MCT1 and lactate were increased. These results lead to suppression of features characteristic for tumor progression, including cell migration, proliferation and invasion, in a colorectal cancer cell line (Caco-2) although there was no difference in MMP expression. Thus, EMMPRIN represents an attractive target molecule for the disruption of cancer proliferation and metastasis. An scFv-M6-1B9 intrabody-based approach could be relevant for cancer gene therapy. © 2014 Nature America, Inc. All rights reserved.
format Journal
author S. Sangboonruang
P. Thammasit
N. Intasai
W. Kasinrerk
C. Tayapiwatana
K. Tragoolpua
spellingShingle S. Sangboonruang
P. Thammasit
N. Intasai
W. Kasinrerk
C. Tayapiwatana
K. Tragoolpua
EMMPRIN reduction via scFv-M6-1B9 intrabody affects α3β1- integrin and MCT1 functions and results in suppression of progressive phenotype in the colorectal cancer cell line Caco-2
author_facet S. Sangboonruang
P. Thammasit
N. Intasai
W. Kasinrerk
C. Tayapiwatana
K. Tragoolpua
author_sort S. Sangboonruang
title EMMPRIN reduction via scFv-M6-1B9 intrabody affects α3β1- integrin and MCT1 functions and results in suppression of progressive phenotype in the colorectal cancer cell line Caco-2
title_short EMMPRIN reduction via scFv-M6-1B9 intrabody affects α3β1- integrin and MCT1 functions and results in suppression of progressive phenotype in the colorectal cancer cell line Caco-2
title_full EMMPRIN reduction via scFv-M6-1B9 intrabody affects α3β1- integrin and MCT1 functions and results in suppression of progressive phenotype in the colorectal cancer cell line Caco-2
title_fullStr EMMPRIN reduction via scFv-M6-1B9 intrabody affects α3β1- integrin and MCT1 functions and results in suppression of progressive phenotype in the colorectal cancer cell line Caco-2
title_full_unstemmed EMMPRIN reduction via scFv-M6-1B9 intrabody affects α3β1- integrin and MCT1 functions and results in suppression of progressive phenotype in the colorectal cancer cell line Caco-2
title_sort emmprin reduction via scfv-m6-1b9 intrabody affects α3β1- integrin and mct1 functions and results in suppression of progressive phenotype in the colorectal cancer cell line caco-2
publishDate 2018
url https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84903593918&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/45468
_version_ 1681422750856511488